Nasdaq:US$14.84 (-0.59) | HKEX:HK$23.65 (-0.10) | AIM:£2.19 (-0.01)
Search Result
Previous Article   |   Next Article
Scientific Publications | 4 Jun 2021

ASCO 2021: A Multicenter Open-Label Phase 1 Study Evaluating the Safety and Tolerability of HMPL-306 in Patients with Locally Advanced or Metastatic Solid Tumors with IDH Mutations